Skip to main content
Clinical Trials/NCT04639349
NCT04639349
Unknown
Not Applicable

Effect of Home Exercise Activity on Cortisol and Depression in COPD Patients During the Pandemic COVID-19

Cairo University1 site in 1 country40 target enrollmentNovember 19, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Obstructive Pulmonary Disease
Sponsor
Cairo University
Enrollment
40
Locations
1
Primary Endpoint
hospital anxiety and depression scale
Last Updated
5 years ago

Overview

Brief Summary

exercise activity during the COVID pandemic is appreciated to be conducted in home especially for chronic chest diseases as chronic obstructive pulmonary disease (COPD) to reduce the chance of viral contamination during the COVID-19 pandemic.

Detailed Description

40 COPD men will be divided to exercise group (20 patients) and control group (20 patients): the exercise group will receive a exercise session contains a fifty minutes exercise training at home with moderate intensity on the available training devices as bicycle or treadmill in addition to 30 minutes of exercising of upper and lower limb, the session will be repeated three times per week for eight weeks. The control group will not be trained

Registry
clinicaltrials.gov
Start Date
November 19, 2020
End Date
March 1, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ali Mohamed Ali ismail

lecturer of Physical Therapy for Cardiovascular / Respiratory Disorder and Geriatrics, Faculty of Physical Therapy, Cairo University

Cairo University

Eligibility Criteria

Inclusion Criteria

  • stable COPD patients
  • patients who will have a training device as bicycle or treadmill in home

Exclusion Criteria

  • diabetic patients
  • renal patients.
  • liver diseases

Outcomes

Primary Outcomes

hospital anxiety and depression scale

Time Frame: It will be measured after eight weeks of training

this a questionnaire that will assess anxiety and depression in COPD patients

cortisol

Time Frame: It will be measured after eight weeks of training

it will be measured in plasma

Secondary Outcomes

  • St. George's respiratory questionnaire(It will be measured after eight weeks of training)
  • pulmonary function test(It will be measured after eight weeks of training)
  • Interleukin-8(It will be measured after eight weeks of training)
  • body mass index(It will be measured after eight weeks of training)
  • six minute walking test(It will be measured after eight weeks of training)

Study Sites (1)

Loading locations...

Similar Trials